NSV Partners III LP - Jun 24, 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
10%+ Owner
Signature
/s/ NSV Partners III, LP, By: Brenda Marex, Chief Financial Officer, and /s/ NSV Partners III GP, LLC, By: Brenda Marex, Chief Financial Officer
Stock symbol
VTYX
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
4
Date filed
6/26/2024, 05:23 PM
Previous filing
Apr 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Other $0 -641K -8.28% $0.00 7.1M Jun 24, 2024 See Footnote F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 NSV Investments I, L.P. distributed 125,651 shares of Common Stock, NSV Investments II, L.P. distributed 232,180 shares of Common Stock, and NSV Investments III, L.P. distributed 283,496 shares of Common Stock, each to their respective limited partners.
F2 NSV Partners III, L.P. is the general partner of NSV Investments I, L.P., NSV Investments II, L.P., and NSV Investments III, L.P.
F3 Somasundaram Subramaniam is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, L.P. is general partner. Mr. Subramaniam is the majority member and managing member NSV Partners II, LLC. Mr. Subramaniam is the majority member and managing member of New Science Ventures, LLC. Mr. Subramaniam disclaims beneficial ownership over the shares owned by each of the NSV Funds (as defined below), except to the extent of his pecuniary interest therein. Mr. Subramaniam is a director of the issuer and files separate reports under Section 16 of the Securities Exchange Act of 1934, as amended.
F4 The shares beneficially owned by the reporting persons consist of: (i) 4,878,420 shares owned by NSV Investments I, L.P., (ii) 1,381,606 shares owned by NSV Partners III, L.P., (iii) 434,423 shares owned by New Science Ventures, LLC, and (iv) 408,520 shares owned by NSV Partners II, LLC (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.